Washington Trust Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40
| Closed | -$7.88K | – | 655 |
|
|
2024
Q3 | $7.88K | Hold |
40
| – | – | ﹤0.01% | 516 |
|
|
2024
Q2 | $8.26K | Sell |
40
-29
| -42% | -$5.99K | ﹤0.01% | 490 |
|
|
2024
Q1 | $18.7K | Hold |
69
| – | – | ﹤0.01% | 406 |
|
|
2023
Q4 | $16.3K | Buy |
69
+1
| +1% | +$237 | ﹤0.01% | 416 |
|
|
2023
Q3 | $13.3K | Hold |
68
| – | – | ﹤0.01% | 427 |
|
|
2023
Q2 | $14.3K | Sell |
68
-25
| -27% | -$5.26K | ﹤0.01% | 415 |
|
|
2023
Q1 | $18.8K | Sell |
93
-37
| -28% | -$7.47K | ﹤0.01% | 426 |
|
|
2022
Q4 | $28.3K | Sell |
130
-211
| -62% | -$46K | ﹤0.01% | 374 |
|
|
2022
Q3 | $67K | Sell |
341
-82
| -19% | -$16.1K | 0.01% | 341 |
|
|
2022
Q2 | $91K | Buy |
423
+26
| +7% | +$5.59K | 0.01% | 310 |
|
|
2022
Q1 | $113K | Buy |
397
+15
| +4% | +$4.27K | 0.01% | 314 |
|
|
2021
Q4 | $144K | Buy |
+382
| New | +$144K | 0.01% | 305 |
|